(11) 98705-3426
TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

MEDIDATA RAVEX

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: VerbalEscritório: US

Snapshot rápido

MEDIDATA RAVEX

ST13

US500000086979160

Classe

42

Pedido

86979160

Registro

4994931

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

26

Atualização mais recente

06/07/2025

Classificação

Registrada

Tipo de marca

Verbal

Classes Nice

42

Data de depósito

11/05/2015

Data de registro

05/07/2016

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

06/11/2021

Última transação

06/07/2025

Escritório responsável

United States Patent and Trademark Office

Código da situação

702

Cadastro oficial

Principal Register

Fundamento do pedido

Intent to use

Primeiro uso

05/09/2015

Primeiro uso no comércio

05/09/2015

Código do desenho

4

Tipo de titular

03

Localização do titular

9th Floor, NY

Examinador

FOSDICK, GEOFFREY

Unidade examinadora

M20

Localização atual

TMO LAW OFFICE 111

Titulares e representantes

Titulares

Medidata Solutions, Inc.

Representantes

Jordan A. LaVine Flaster Greenberg P C

Classificação técnica

Classes Nice

Classe 42

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 42

Software as a service (saas) solutions featuring software for capturingmanaging and reporting data and information in the fields of medical clinical trials and medical researchfor designingmanagingexecuting medical clinical trials and medical research and medical clinical trial and medical research protocolsfor forecasting and benchmarking budgets and costs in medical clinical trials and medical researchfor medical coding in medical clinical trials and medical researchfor the collection of information and data in medical clinical trials and medical researchfor evaluating and measuring the performance and results of medical clinical trials and medical researchfor capturingmanagingorganizing and reporting the results of medical clinical trials and medical researchfor monitoring and events capture in the nature of gathering and organizing information and data generated in medical clinical trials and medical researchfor medical clinical trial and medial research user and learning managementfor medical clinical trial and medical research operational reporting and analyticsfor medical clinical trial and medical research patient randomization and supply management; providing temporary use of online non-downloadable computer software for capturingmanaging and reporting data and information in the fields of medical clinical trials and medical researchfor designingmanagingexecuting medical clinical trials and medical research and medical clinical trial and medical research protocolsfor forecasting and benchmarking budgets and costs in medical clinical trials and medical researchfor medical coding in medical clinical trials and medical researchfor the collection of information and data in medical clinical trials and medical researchfor evaluating and measuring the performance and results of medical clinical trials and medical researchfor managingorganizing and reporting the results of medical clinical trials and medical researchfor monitoring and events capture in the nature of gathering and organizing information and data generated in medical clinical trials and medical researchfor medical clinical trial and medical research user and learning managementfor medical clinical trial and medical research operational reporting and analyticsfor medical clinical trial and medical research patient randomization and supply management

Publicações

Histórico de despachos e eventos da marca no USPTO.

26 publicações encontradas

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

05/07/2025

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

06/11/2021

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

06/11/2021

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

06/11/2021

E815

TEAS SECTION 8 & 15 RECEIVED

03/08/2021

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

05/07/2021

R.PR

REGISTERED-PRINCIPAL REGISTER

05/07/2016

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

02/06/2016

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

01/06/2016

SUPC

STATEMENT OF USE PROCESSING COMPLETE

25/05/2016

DPCC

DIVISIONAL PROCESSING COMPLETE

25/05/2016

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

24/05/2016

IUAF

USE AMENDMENT FILED

13/04/2016

DRRR

DIVISIONAL REQUEST RECEIVED

13/04/2016

EISU

TEAS STATEMENT OF USE RECEIVED

13/04/2016

ERTD

TEAS REQUEST TO DIVIDE RECEIVED

13/04/2016

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

13/10/2015

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

18/08/2015

PUBO

PUBLISHED FOR OPPOSITION

18/08/2015

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

29/07/2015

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

16/07/2015

ALIE

ASSIGNED TO LIE

16/07/2015

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

01/07/2015

DOCK

ASSIGNED TO EXAMINER

24/06/2015

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

19/05/2015

NWAP

NEW APPLICATION ENTERED

14/05/2015

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace MEDIDATA RAVEX ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.